FR2197576A1 - - Google Patents

Info

Publication number
FR2197576A1
FR2197576A1 FR7331447A FR7331447A FR2197576A1 FR 2197576 A1 FR2197576 A1 FR 2197576A1 FR 7331447 A FR7331447 A FR 7331447A FR 7331447 A FR7331447 A FR 7331447A FR 2197576 A1 FR2197576 A1 FR 2197576A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7331447A
Other versions
FR2197576B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
University of Illinois Foundation
Original Assignee
University of Illinois
University of Illinois Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285036A external-priority patent/US3823228A/en
Application filed by University of Illinois, University of Illinois Foundation filed Critical University of Illinois
Publication of FR2197576A1 publication Critical patent/FR2197576A1/fr
Application granted granted Critical
Publication of FR2197576B1 publication Critical patent/FR2197576B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7331447A 1972-08-30 1973-08-30 Expired FR2197576B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00285036A US3823228A (en) 1971-09-29 1972-08-30 Tge virus vaccine

Publications (2)

Publication Number Publication Date
FR2197576A1 true FR2197576A1 (fr) 1974-03-29
FR2197576B1 FR2197576B1 (fr) 1976-09-03

Family

ID=23092469

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7331447A Expired FR2197576B1 (fr) 1972-08-30 1973-08-30

Country Status (9)

Country Link
JP (1) JPS535371B2 (fr)
AR (1) AR197158A1 (fr)
AU (1) AU5949773A (fr)
CA (1) CA1023266A (fr)
DE (1) DE2343570A1 (fr)
FR (1) FR2197576B1 (fr)
GB (1) GB1440214A (fr)
NL (1) NL7312032A (fr)
PH (1) PH10296A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009577A1 (fr) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. Préparation d'un vaccin oral et méthode pour augmenter la résistance des porcs contre la dysentérie porcine
EP0080341A2 (fr) * 1981-11-20 1983-06-01 A/S Alfred Benzon Formulations pharmaceutiques à unités multiples

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584561Y2 (ja) * 1980-11-26 1983-01-26 日本濾過器株式会社 気泡分離装置
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
DE19741114C2 (de) * 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1560264A (fr) * 1966-08-31 1969-03-21
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1560264A (fr) * 1966-08-31 1969-03-21
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009577A1 (fr) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. Préparation d'un vaccin oral et méthode pour augmenter la résistance des porcs contre la dysentérie porcine
EP0080341A2 (fr) * 1981-11-20 1983-06-01 A/S Alfred Benzon Formulations pharmaceutiques à unités multiples
EP0080341A3 (en) * 1981-11-20 1983-09-14 A/S Alfred Benzon Pharmaceutical multiple-units formulation

Also Published As

Publication number Publication date
NL7312032A (nl) 1975-03-04
FR2197576B1 (fr) 1976-09-03
JPS4962618A (fr) 1974-06-18
DE2343570A1 (de) 1974-03-14
GB1440214A (en) 1976-06-23
AU5949773A (en) 1975-02-27
CA1023266A (fr) 1977-12-27
AR197158A1 (es) 1974-03-15
JPS535371B2 (fr) 1978-02-27
PH10296A (en) 1976-11-10

Similar Documents

Publication Publication Date Title
FR2197576A1 (fr)
JPS5326498Y2 (fr)
CH577264A5 (fr)
BG17145A1 (fr)
BG17676A1 (fr)
BG18781A1 (fr)
BG20645A1 (fr)
CH533572A4 (fr)
CH559489A5 (fr)
CH559550A5 (fr)
CH560870A5 (fr)
CH561486A5 (fr)
CH562334A5 (fr)
CH563553A5 (fr)
CH563676A5 (fr)
CH563766A5 (fr)
CH564948A5 (fr)
CH565321A5 (fr)
CH565885A5 (fr)
CH566060A5 (fr)
CH566631A5 (fr)
CH566815A5 (fr)
CH567003A5 (fr)
CH567592A5 (fr)
CH567700A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse